Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × gadopiclenol × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 91 Nivolumab 56 Cyclophosphamide 22 Ipilimumab 17 atezolizumab 15 Radiosurgery 13 Paclitaxel 13 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Interleukin-2 12 Docetaxel 12 fludarabine 11 Carboplatin 11 Pemetrexed 10 spartalizumab 9 Biopsy 9 durvalumab 8 Cisplatin 8 Radiotherapy 7 Immune Checkpoint Inhibitors 7 Blood Specimen Collection 7 cemiplimab 6 avelumab 6 aldesleukin 6 Gemcitabine 6 Drug Therapy 6 Bevacizumab 6 trametinib 5 tislelizumab 5 poly ICLC 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡